Correlation between progression free survival and response rate in patients with metastatic colorectal carcinoma
✍ Scribed by Christophe Louvet; Aimery de Gramont; Christophe Tournigand; Pascal Artru; Frédérique Maindrault-Goebel; Marcel Krulik
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 95 KB
- Volume
- 91
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## BACKGROUND. Clinicopathologic variables, carcinoembryonic antigen (CEA), nuclear DNA ploidy, and proliferating cell nuclear antigen labeling index (PCNA LI) have been studied for their effect on patients with various types of cancer. ## METHODS. Thirteen clinicopathologic variables, preoperati
The p21 protein inhibits cyclin-dependent kinases and mediates cell-cycle arrest and cell differentiation. It is induced by wild-type p53, but not by mutant p53. This study of 75 patients with endometrial carcinoma investigates the relationship between p21 expression and the functional status of p53
BACKGROUND. Adjuvant chemotherapy for colorectal carcinoma was found to improve survival of patients with American Joint Committee on Cancer/International Union Against Cancer Stage III disease. The usefulness of chemotherapy in patients with Stage II disease continues to be debated, and it is likel